Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
CellMatrix AB
AB
Active
Org 5565630026
Medicinaregatan 8 A, 413 90
Göteborg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1999 · 27 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
CellMatrix AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
0
0
0
0
0
Staff expenses
−0
—
—
—
—
EBITDA
−18
−16
−19
−26
−25
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−18
−16
−19
−26
−25
Net financials
−55
4
3
—
−80
Profit before tax
69
9
−4
−2
−42
Tax
−27
−3
−0
−0
−0
Net profit
42
6
−4
−2
−42
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
247
317
432
648
1 173
Equity
202
160
254
458
960
Long-term debt
0
0
0
0
0
Short-term debt
45
15
15
15
15
Total debt
45
15
15
15
15
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
81,8 %
This company
38,2 %
Market median
This company
Market median
114% above market
2021
2025
Return on equity
20,8 %
This company
18,4 %
Market median
This company
Market median
13% above market
2021
2025
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0,22×
This company
0,62×
Market median
This company
Market median
65% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on CellMatrix AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
